Prescription for Better Access
With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs and the insurance industry increasing the use of more restricti…
Mar 20th, 2025 |
51:29
Value in Prescription Drugs – What Does It Really Mean?
In this episode, we explore the complex and often debated concept of value in prescription drugs. They discuss how different stakeholders—payers…
Feb 20th, 2025 |
43:33
An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
In this episode, we interview Sarah Emond, MPP, President and CEO of the Institute for Clinical and Economic Review (ICER). Sarah joined ICER over 15…
Dec 18th, 2024 |
47:41
2025 Outlook with Stacie Dusetzina, Ph.D., Vanderbilt University
In this episode, we sit down with Stacie Dusetzina, Ph.D., a leading health economist from Vanderbilt University Medical Center to discuss the critica…
Dec 4th, 2024 |
53:05
Cell and Gene Therapy Access Challenges
In our second of three episodes in conjunction with members of ACCESS Forum, we engage with leading experts to uncover the multifaceted challenges of…
Oct 22nd, 2024 |
54:25
Global vs. US Drug Pricing and Market Access
In this episode, we sit down with leading Market Access experts and members of ACCESS Forum to compare and contrast the drug pricing and access system…
Sep 12th, 2024 |
44:50
22. Honoring the Work of Healthcare Advocates
In this episode, we explore the evolving role of healthcare and patient advocates and how this profession has become an essential part of the healthca…
Aug 20th, 2024 |
45:25
Evolution of PBM's
In this episode, we explore the evolution and future of the Pharmacy Benefit Management (PBM) industry with insights from two seasoned pharma managed…
Jul 16th, 2024 |
49:00
How Access Challenges Impact the Drug Development Pipeline
In this episode, we dive into the pharmaceutical industry's research and drug development side and the real threat that today’s access and affor…
Jun 4th, 2024 |
33:45
Interviews from Asembia’s AXS24 Summit, Part 2
This is the second of two episodes dedicated to Asembia’s AXS24 Summit, where we were honored to be a media partner. In this episode, we learn f…
May 24th, 2024 |
35:40
Interviews from Asembia's AXS24 Summit, Part 1 of 2
Asembia’s AXS24 Summit, a pinnacle of specialty drug and healthcare discussions, concluded earlier this month. We are thrilled to share that our…
Apr 25th, 2024 |
46:45
Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research
In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enabl…
Mar 28th, 2024 |
43:34
Interview with Victor Bulto, President, US, Novartis
In this important podcast episode, we interview Victor Bulto, President, US for Novartis, to discuss the company's efforts to develop groundbreaking t…
Feb 27th, 2024 |
42:34
Biosimilar's Role in Improving Patient Access
Biosimilars are entering the market at their fastest pace ever. In this episode, we interview a renowned health economist and an expert consultant in…
Jan 30th, 2024 |
49:31
2024 Policy Preview: An Interview with Dr. Mark McClellan
Scott and Mark welcome Dr. Mark McClellan, a distinguished health policy expert who has served as the Commissioner of the FDA and the Administrator of…
Dec 22nd, 2023 |
35:22
Episode 13: The Sustainability of Innovation: An Interview with Rachel King, CEO, BIO
In our 2023 podcasts, there have been a series of revelations about the complexity and unintended consequences related to drug access and affordabilit…
Nov 16th, 2023 |
40:00
Episode 12: How Alternative Funding Programs Exploit Patient Assistance Programs
In this episode, we investigate the rise of Alternative Funding Programs (AFPs) that bypass coverage for vital specialty drugs. Kyle Crowell, an…
Oct 17th, 2023 |
55:23
Episode 11: Obesity Week 2023: An Interview with Dr. Angela Fitch, President, Obesity Medicine Association
Patients are experiencing remarkable weight loss thanks to the new generation of GLP-1’s and the downstream health benefits may go well beyond d…
Sep 29th, 2023 |
41:44
Episode 10: Empowering Employers to Improve Patient Access
Employers are discovering this fall that they are expected to shoulder a 6% health insurance increase for 2024. What can employers do to combat the ac…
Aug 10th, 2023 |
49:20
Physician Offices: Fighting for Patient Access
Many of the most beneficial therapies are prescribed or administered within physician offices yet these providers face a multitude of challenges attem…
Jul 6th, 2023 |
53:53
Washington's Influence on Patient Access
This episode delves into the intricate web of Washington's influence on patient access, exploring the multifaceted factors that shape healthcare legis…
Jun 1st, 2023 |
43:35
Tackling Copay Accumulators and Maximizers
In this podcast, we interview a consultant and a leading patient advocate to better understand and explore the challenges of copay accumulator and max…
May 9th, 2023 |
46:25
PBM Perspective: An Interview with Industry Veteran Mesfin Tegenu
Pharmacy benefit managers (PBM’s) manage the drug benefits for millions of Americans and as a result, they can have a positive or negative impac…
Apr 18th, 2023 |
47:16
Understanding ICER: An interview with founder Dr. Steven Pearson
In this episode, we interview Dr. Steven Pearson, the founder and President of the Institute for Clinical and Economic Review (ICER). Over the past 16…
Mar 28th, 2023 |
46:30
Understanding Drug Pricing: An Interview with Health Economist James Robinson
In this foundational episode about drug pricing, we interview Dr. Jamie Robinson, the Leonard D. Schaeffer Professor of Health Economics, and Director…
Mar 7th, 2023 |
39:25
Breaking Down Barriers: An Interview with Peyton Howell
This episode features an interview with Peyton Howell discussing the evolution of patient access over the past three decades, the creation of the hub…
Feb 15th, 2023 |
46:55
Patient Voices: The Value and Challenges of Access
In this episode, co-hosts Mark Hansan and Dr. Scott Howell interview two patients who share their personal journeys, how medicine has helped them, the…
Jan 31st, 2023 |
51:21
2023: Looking Ahead in Patient Access
In this episode Mark and Scott interview Dave Moules, former Pfizer SVP, Payer and Channel Access to look at the year ahead in patient access.
David…
Jan 23rd, 2023 |
16:11
Podcast Preview: Getting to Know Your Co-hosts
In this preview episode, you will have the opportunity to get to know co-hosts Mark Hansan and Dr. Scott Howell and why they have come together to lau…